Skip to search formSkip to main contentSkip to account menu

Omnitrope

National Institutes of Health

Related topics

Related topics

4 relations
1.5 ML Somatropin 6.67 MG/ML Cartridge [Omnitrope]Somatropin 5 MG/ML Injectable Solution [Omnitrope]

Broader (2)

Human Growth HormoneSomatropin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Ten years’ clinical experience with biosimilar human growth hormone: a review of efficacy data
In 2006, the European Medicines Agency (EMA) approved Omnitrope® as a biosimilar recombinant human growth hormone (rhGH), on the… 
Review
2017
Review
2017
Ten years of clinical experience with biosimilar human growth hormone: a review of safety data
Safety concerns for recombinant human growth hormone (rhGH) treatments include impact on cancer risk, impact on glucose… 
Review
2017
Review
2017
Ten years of biosimilar recombinant human growth hormone in Europe
Recombinant human growth hormone (rhGH) has been in clinical use for more than 30 years. With the expiration of patent… 
2017
2017
Long-term safety and efficacy of Omnitrope® in adults with growth hormone deficiency: Italian interim analysis of the PATRO Adults study
PurposeTo report the long-term effectiveness and safety of the recombinant human growth hormone Omnitrope®, a somatropin… 
2016
2016
Long-term safety and efficacy of Omnitrope®, a somatropin biosimilar, in children requiring growth hormone treatment: Italian interim analysis of the PATRO Children study
BackgroundPATRO Children is an ongoing observational, longitudinal, non-interventional, global post-marketing surveillance study… 
2010
2010
Bioequivalence Studies of Omnitrope, the First Biosimilar/rhGH Follow‐on Protein: Two Comparative Phase 1 Randomized Studies and Population Pharmacokinetic Analysis
This article discusses the bioequivalence of Omnitrope (Sandoz's rhGH biosimilar) and Genotropin (reference rhGH product… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)